Angela A.G. van Tilborg

1.6k total citations
23 papers, 1.1k citations indexed

About

Angela A.G. van Tilborg is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Angela A.G. van Tilborg has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Angela A.G. van Tilborg's work include Bladder and Urothelial Cancer Treatments (8 papers), Epigenetics and DNA Methylation (6 papers) and Genetic factors in colorectal cancer (5 papers). Angela A.G. van Tilborg is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Epigenetics and DNA Methylation (6 papers) and Genetic factors in colorectal cancer (5 papers). Angela A.G. van Tilborg collaborates with scholars based in Netherlands, United States and United Kingdom. Angela A.G. van Tilborg's co-authors include Ellen C. Zwarthoff, Cornelis J.F. Van Noorden, Philip C. De Witt Hamer, Irene Lurkin, Theodorus van der Kwast, A. de Vries, Paul P. Eijk, Dirk Troost, Bauke Ylstra and Sieger Leenstra and has published in prestigious journals such as PLoS ONE, Cancer Cell and Oncogene.

In The Last Decade

Angela A.G. van Tilborg

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela A.G. van Tilborg Netherlands 15 690 305 266 201 135 23 1.1k
Yanli Su United States 15 790 1.1× 472 1.5× 127 0.5× 303 1.5× 198 1.5× 22 1.4k
Vinay Sagar United States 19 712 1.0× 361 1.2× 153 0.6× 231 1.1× 214 1.6× 46 1.3k
Ivan Ischenko Germany 19 621 0.9× 507 1.7× 168 0.6× 269 1.3× 140 1.0× 22 1.2k
Frauke Devens Germany 15 657 1.0× 302 1.0× 153 0.6× 306 1.5× 125 0.9× 17 1.0k
Kenneth R. Shroyer United States 22 860 1.2× 350 1.1× 260 1.0× 229 1.1× 210 1.6× 33 1.5k
Deqin Ma United States 21 825 1.2× 196 0.6× 135 0.5× 217 1.1× 249 1.8× 46 1.4k
Sudheer Kumar Gara United States 20 545 0.8× 283 0.9× 212 0.8× 260 1.3× 63 0.5× 35 1.2k
Katrin E. Rhodes United States 13 575 0.8× 560 1.8× 214 0.8× 123 0.6× 314 2.3× 21 1.3k
Robert T. Jones United States 8 513 0.7× 380 1.2× 217 0.8× 154 0.8× 128 0.9× 20 1.2k
Marianna B. Ruzinova United States 15 822 1.2× 504 1.7× 121 0.5× 286 1.4× 111 0.8× 36 1.4k

Countries citing papers authored by Angela A.G. van Tilborg

Since Specialization
Citations

This map shows the geographic impact of Angela A.G. van Tilborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela A.G. van Tilborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela A.G. van Tilborg more than expected).

Fields of papers citing papers by Angela A.G. van Tilborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela A.G. van Tilborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela A.G. van Tilborg. The network helps show where Angela A.G. van Tilborg may publish in the future.

Co-authorship network of co-authors of Angela A.G. van Tilborg

This figure shows the co-authorship network connecting the top 25 collaborators of Angela A.G. van Tilborg. A scholar is included among the top collaborators of Angela A.G. van Tilborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela A.G. van Tilborg. Angela A.G. van Tilborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geels, Yvette P., Louis J.M. van der Putten, Angela A.G. van Tilborg, et al.. (2016). Immunohistochemical Profiles of Endometrioid Endometrial Carcinomas With and Without Metastatic Disease. Applied immunohistochemistry & molecular morphology. 26(3). 173–179. 6 indexed citations
2.
Tilborg, Angela A.G. van, et al.. (2015). Prognostic significance of highly sulfated chondroitin sulfates in ovarian cancer defined by the single chain antibody GD3A11. Gynecologic Oncology. 140(3). 527–536. 31 indexed citations
3.
Geels, Yvette P., Louis J.M. van der Putten, Angela A.G. van Tilborg, et al.. (2015). Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecologic Oncology. 137(2). 245–251. 14 indexed citations
4.
Tilborg, Angela A.G. van, Fred C.G.J. Sweep, Anneke Geurts‐Moespot, et al.. (2014). Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids. International Journal of Oncology. 44(4). 1394–1400. 10 indexed citations
5.
Tilborg, Angela A.G. van, et al.. (2014). Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: ‘When sweet turns sour’. Gynecologic Oncology. 135(2). 371–381. 30 indexed citations
6.
Kandimalla, Raju, Roy Masius, Willemien Beukers, et al.. (2013). A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine. Clinical Cancer Research. 19(17). 4760–4769. 51 indexed citations
7.
Geels, Yvette P., Johanna M.A. Pijnenborg, Angela A.G. van Tilborg, et al.. (2013). Histopathologic assessment of the entire endometrium in asymptomatic women. Human Pathology. 44(10). 2293–2301. 11 indexed citations
8.
Kandimalla, Raju, Angela A.G. van Tilborg, Lucie C. Kompier, et al.. (2012). Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers. European Urology. 61(6). 1245–1256. 95 indexed citations
9.
Tilborg, Angela A.G. van, Lucie C. Kompier, Irene Lurkin, et al.. (2012). Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood. PLoS ONE. 7(8). e43345–e43345. 15 indexed citations
10.
Lurkin, Irene, Robert Stoehr, Carolyn D. Hurst, et al.. (2010). Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes. PLoS ONE. 5(1). e8802–e8802. 79 indexed citations
11.
Mir, Shahryar E., Philip C. De Witt Hamer, Przemek M. Krawczyk, et al.. (2010). In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma. Cancer Cell. 18(3). 244–257. 243 indexed citations
12.
Kompier, Lucie C., Angela A.G. van Tilborg, & Ellen C. Zwarthoff. (2009). Bladder cancer: Novel molecular characteristics, diagnostic, and therapeutic implications. Urologic Oncology Seminars and Original Investigations. 28(1). 91–96. 8 indexed citations
13.
Hamer, Philip C. De Witt, Angela A.G. van Tilborg, Paul P. Eijk, et al.. (2007). The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene. 27(14). 2091–2096. 174 indexed citations
14.
Tilborg, Angela A.G. van, A. de Vries, Johan M. Kros, et al.. (2005). Chromosomal Instability in Meningiomas. Journal of Neuropathology & Experimental Neurology. 64(4). 312–322. 13 indexed citations
15.
Rhijn, Bas W.G. van, Angela A.G. van Tilborg, Irene Lurkin, et al.. (2002). Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. European Journal of Human Genetics. 10(12). 819–824. 126 indexed citations
16.
Tilborg, Angela A.G. van, A. de Vries, & Ellen C. Zwarthoff. (2001). The chromosome 9q genesTGFBR1,TSC1, andZNF189 are rarely mutated in bladder cancer. The Journal of Pathology. 194(1). 76–80. 23 indexed citations
17.
Tilborg, Angela A.G. van. (2000). Molecular evolution of multiple recurrent cancers of the bladder. Human Molecular Genetics. 9(20). 2973–2980. 77 indexed citations
18.
19.
Tilborg, Angela A.G. van, et al.. (1998). Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. International Journal of Cancer. 75(1). 9–14. 18 indexed citations
20.
Kummer, J. Alain, Paul P. Tak, Brigitta M. N. Brinkman, et al.. (1994). Expression of Granzymes A and B in Synovial Tissue from Patients with Rheumatoid Arthritis and Osteoarthritis. Clinical Immunology and Immunopathology. 73(1). 88–95. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanli Su Breakdown of academic impact, for papers by Vinay Sagar Breakdown of academic impact, for papers by Ivan Ischenko Breakdown of academic impact, for papers by Frauke Devens Breakdown of academic impact, for papers by Kenneth R. Shroyer Breakdown of academic impact, for papers by Deqin Ma Breakdown of academic impact, for papers by Sudheer Kumar Gara Breakdown of academic impact, for papers by Katrin E. Rhodes Breakdown of academic impact, for papers by Robert T. Jones Breakdown of academic impact, for papers by Marianna B. Ruzinova
Rankless by CCL
2026